Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 4/2007

01-12-2007 | Original Article

Hypersplenism is related to age of onset of liver disease

Authors: P. A. McCormick, S. Walker, R. Benepal

Published in: Irish Journal of Medical Science (1971 -) | Issue 4/2007

Login to get access

Abstract

Background

The aim of this study was to investigate whether hypersplenism is related to the age of onset of liver disease.

Methods

Hypersplenism was assessed in 84 consecutive cirrhotic patients attending a university hospital liver clinic.

Results

Hypersplenism was present in 78% of patients and severe in 39%. Severe hypersplenism was more common in patients with cystic fibrosis liver disease (88%, P < 0.0001) and autoimmune hepatitis (60%, P = 0.0006) compared to alcoholic cirrhosis (12%). There was a significant correlation between patient age and platelet count r = 0.525, P < 0.0001 in the group as a whole and for the sub-group of patients with autoimmune hepatitis r = 0.54, P = 0.047. There was a negative correlation between age and spleen size r = −0.611, P < 0.0001.

Conclusion

Younger patients had lower platelet counts, larger spleens and a higher incidence of hypersplenism suggesting that hypersplenism is significantly related to the age of onset of chronic liver disease.
Literature
1.
go back to reference McCormick PA (2007) Hypersplenism. In: Rodes J, Benhamou JP, Blei AT, Reichen J, Rizzetto M (eds) Textbook of hepatology. From basic science to clinical practice, 3rd edn. Blackwell, Oxford, pp 771–778 McCormick PA (2007) Hypersplenism. In: Rodes J, Benhamou JP, Blei AT, Reichen J, Rizzetto M (eds) Textbook of hepatology. From basic science to clinical practice, 3rd edn. Blackwell, Oxford, pp 771–778
2.
go back to reference Mutchnick MG, Lerner E, Conn HO (1980) Effect of portocaval anastomosis on hypersplenism. Dig Dis Sci 25:929–938PubMedCrossRef Mutchnick MG, Lerner E, Conn HO (1980) Effect of portocaval anastomosis on hypersplenism. Dig Dis Sci 25:929–938PubMedCrossRef
3.
go back to reference Liangpunsakul S, Ulmer BJ, Chalasani N (2003) Predictors and implications of severe hypersplenism in patients with cirrhosis. Am J Med Sci 326:111–116PubMedCrossRef Liangpunsakul S, Ulmer BJ, Chalasani N (2003) Predictors and implications of severe hypersplenism in patients with cirrhosis. Am J Med Sci 326:111–116PubMedCrossRef
4.
go back to reference Bashour FN, Teran JC, Mullen KD (2000) Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease. Am J Gastroenterol 95:2936–2939PubMedCrossRef Bashour FN, Teran JC, Mullen KD (2000) Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease. Am J Gastroenterol 95:2936–2939PubMedCrossRef
5.
go back to reference El-Khishen MA, Henderson JM, Millikan WJ, Kutner MH, Warren WD (1985) Splenectomy is contraindicated for thrombocytopenia secondary to portal hypertension. Surgery. Gynecol Obstet 160:233–238 El-Khishen MA, Henderson JM, Millikan WJ, Kutner MH, Warren WD (1985) Splenectomy is contraindicated for thrombocytopenia secondary to portal hypertension. Surgery. Gynecol Obstet 160:233–238
6.
go back to reference Psacharopolous HT, Howard ER, Portman B, Mowat AP, Williams R (1981) Hepatic complications of cystic fibrosis. Lancet 2(8237):78–80CrossRef Psacharopolous HT, Howard ER, Portman B, Mowat AP, Williams R (1981) Hepatic complications of cystic fibrosis. Lancet 2(8237):78–80CrossRef
7.
go back to reference Da Silva LCCFJ (1992) Hepatosplenic schistosomiasis. Pathophysiology and treatment. Gastroenterol Clin North Am 21:163–177PubMed Da Silva LCCFJ (1992) Hepatosplenic schistosomiasis. Pathophysiology and treatment. Gastroenterol Clin North Am 21:163–177PubMed
8.
go back to reference Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–649PubMedCrossRef Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–649PubMedCrossRef
9.
go back to reference Qasim A, McCormick PA, Tajuddin T, Zaman MB, Traynor O, Hegarty J et al (2007) Improved survival outcomes for liver transplantation. Ir Med J 100:389–390PubMed Qasim A, McCormick PA, Tajuddin T, Zaman MB, Traynor O, Hegarty J et al (2007) Improved survival outcomes for liver transplantation. Ir Med J 100:389–390PubMed
10.
go back to reference Kenny-Walsh E, for the Irish Hepatology Research Group (1999) Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. N Engl J Med 340:1228–1233PubMedCrossRef Kenny-Walsh E, for the Irish Hepatology Research Group (1999) Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. N Engl J Med 340:1228–1233PubMedCrossRef
11.
go back to reference Shah SHA, Hayes PC, Allan PL, Finlayson ND (1996) Measurement of spleen size and its relation to hypersplenism and portal hemodynamics in portal hypertension due to hepatic cirrhosis. Am J Gastroenterol 91:2580–2583PubMed Shah SHA, Hayes PC, Allan PL, Finlayson ND (1996) Measurement of spleen size and its relation to hypersplenism and portal hemodynamics in portal hypertension due to hepatic cirrhosis. Am J Gastroenterol 91:2580–2583PubMed
12.
go back to reference Soper NJ, Rikkers LF (1982) Effect of operations for variceal hemorrhage on hypersplenism. Am J Surg 144:700–703PubMedCrossRef Soper NJ, Rikkers LF (1982) Effect of operations for variceal hemorrhage on hypersplenism. Am J Surg 144:700–703PubMedCrossRef
Metadata
Title
Hypersplenism is related to age of onset of liver disease
Authors
P. A. McCormick
S. Walker
R. Benepal
Publication date
01-12-2007
Publisher
Springer-Verlag
Published in
Irish Journal of Medical Science (1971 -) / Issue 4/2007
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-007-0089-8

Other articles of this Issue 4/2007

Irish Journal of Medical Science (1971 -) 4/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine